SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

75,736.51 -396.30
( -0.52%)

Global Indices

Nasdaq

53,435.25 -271.85
(-0.51%)

Dow Jones

7,739.60 -29.11
(-0.37%)

Hang Seng

66,225.50 1,204.56
(1.85%)

Nikkei 225

10,817.95 -13.14
(-0.12%)

Forex

USD-INR

94.44 -0.05
(-0.05%)

EUR-INR

109.67 -0.05
(-0.04%)

GBP-INR

127.62 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.9540829

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

144.03

95570.85

EPS(TTM)

Face Value()

Div & Yield %

7.95

0.7

Back

srs ltd

Anant Raj consolidated net profit rises 18.88% in the June 2026 quarter

Aug 10,2026

Net profit of Anant Raj rose 18.88% to Rs 149.64 crore in the quarter ended June 2026 as against Rs 125.88 crore during the previous quarter ended June 2025. Sales rose 6.58% to Rs 631.40 crore in the quarter ended June 2026 as against Rs 592.41 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	631.40	592.41	7
OPM %	29.04	25.43	-
PBDT	201.54	158.27	27
PBT	185.33	150.38	23
NP	149.64	125.88	19

75,736.51 -396.30 ( -0.52%)

53,435.25 -271.85 (-0.51%)

7,739.60 -29.11 (-0.37%)

66,225.50 1,204.56 (1.85%)

10,817.95 -13.14 (-0.12%)

94.44 -0.05 (-0.05%)

109.67 -0.05 (-0.04%)

127.62 -0.01 (-0.01%)

0.60 0.00 (0.12%)